News
January 20, 2023
Earlier in 2022, FRONTEO was pleased to announce the release of its proprietary e-Discovery hosting platform called KIBIT Automator Review or KAMR.
November 25, 2019
October 23, 2017
July 28, 2021
By building KIBIT Automator on a cloud environment, we will create a highly reliable service platform that meets a large amount of data processing demand, improve data analysis efficiency, and reduce man-hours and costs.
August 29, 2023
NEW YORK, August 29, 2023 – FRONTEO (TSE: 2158) announces today that the number of registered members of the FRONTEO Legal Link Portal (https://legal.fronteo.com/fllp/; hereinafter "FLLP"), one of the largest membership-based legal platforms in Japan, has reached 12,000.
April 15, 2020
February 6, 2024
Enhanced function of the Drug Discovery AI Factory, analyze cutting-edge academic articles to propose highly novel target molecules and hypotheses
September 9, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
November 12, 2024
FRONTEO, Inc. (Head Office: Minato-ku, Tokyo; President and CEO: Masahiro Morimoto; hereafter "FRONTEO") is pleased to announce that an agreement has been reached to provide Daiichi Sankyo Co., Ltd. (Head Office: Chuo-ku, Tokyo; President and COO: Hiroyuki Okuzawa; hereafter "Daiichi Sankyo") with analysis services using Drug Discovery AI Factory (hereafter "DDAIF")* to analyze text information from toxicity study databases and reports.
November 10, 2023
FRONTEO Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto; hereinafter “FRONTEO”) and Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa City, Kanagawa Prefecture; President: Nobuhiko Yamada; hereinafter “Axcelead DDP”) have entered into a master collaboration agreement for AI drug discovery support.
January 16, 2025
FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.
November 2, 2021
KIBIT Automator, an AI-based e-discovery and digital forensics platform, runs on Microsoft Azure, the world's most secure environment.
March 8, 2023
Platform connecting companies and lawyers with legal industry focused video content
NEW YORK, March 7, 2023 – FRONTEO (TSE: 2158) has announced that the number of registered members of its membership portal site, FRONTEO Legal Link Portal (https://legal.fronteo.com/fllp/, referred to as "FLLP") , reached 10,000 on February 15, 2023.
April 15, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
February 15, 2024
Tokyo, Japan, February 14, 2024 – FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO") and Shionogi Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi") are pleased to announce that we have entered into a strategic business partnership agreement for the dementia-related AI program and depression-related AI program.
September 26, 2023
NEW YORK, September 25, 2023 – FRONTEO (TSE: 2158) announces that it has received a patent application notice from the Japan Patent Office for a new technology that uses its proprietary AI engine "KIBIT" to analyze hashed¹⁾ confidential information that cannot be decrypted.
January 31, 2023
Reduced review time and costs for companies and attorneys involved in litigation
May 13, 2024
FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO"), Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi"), and Suzuken Co., Ltd. (Head Office: Nagoya, Japan; President and CEO: Shigeru Asano; hereafter "Suzuken") are pleased to announce that we will collaborate with the aim of implementing the conversational dementia diagnosis support AI program in society.